$2.09
-0.310 (-12.92%)
At Close: Jun 22, 2026
Innocan Pharma and Polyflame Announce an Exclusive Distribution Agreement in France
03:00am, Thursday, 22'nd Apr 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 22, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the sign
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 6, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is proud to announce the additio
Innocan Reports Q4 2020 Financial Results
03:00am, Thursday, 01'st Apr 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 1, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce today it
Leading American Dermatologist Dr. Mitchell Kline to Join Innocan Pharma's Scientific Advisory Committee
04:00am, Tuesday, 23'rd Mar 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 23, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the "Company" or "Innocan") is proud to announce the add
Innocan Pharma Announces Proceeds of CDN $ 3.1M from the Exercise of Warrants Since January 1, 2021
04:20pm, Tuesday, 16'th Mar 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 16, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the "Company" or "Innocan") today announces that since J
Innocan Pharma Announces Patent Application for Novel Cannabis-Based Anti-Itch Treatment
03:00am, Wednesday, 10'th Mar 2021
Herzlia, Israel and Calgary, Alberta--(Newsfile Corp. - March 10, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the "Company" or "Innocan") filed an international patent
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - February 22, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the "Company" or "Innocan"), is pleased to announce
Innocan Pharma Announces Proceeds of CDN $ 1.8M from the Exercise of Warrants Since December 1, 2020
04:00pm, Thursday, 28'th Jan 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 28, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the "Company" or "Innocan") today announces that since
Innocan Pharma Announces Successful Production of CBD Loaded Liposomes under Aseptic Conditions
02:00am, Friday, 22'nd Jan 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 22, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC PINK: INNPF) (the "Company" or "Innocan"), is pleased to announce
Innocan Pharma Successfully Completes Large Scale Production of Exosomes
04:00pm, Thursday, 14'th Jan 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 14, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the "Company" or "Innocan"), is pleased to announce th
Innocan Pharma Announces the Launch of Its Commercial Website
03:00am, Tuesday, 05'th Jan 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 5, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the "Company" or "Innocan"), is pleased to announce the
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - December 16, 2020) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the "Company" or "Innocan"), is pleased to announce t
Sign In
Buy INNPF